Gain insight into the mind of a scientist-turned-investor. Eventide Managing Director and Senior Research Analyst Kyle Rasbach, MD, PhD, shares his unique perspective on the healthcare industry and why he made the career shift from developing therapies to investing in them.

This communication is provided for informational purposes only and expresses views of Eventide Asset Management, LLC (“Eventide”), an investment adviser. There is no guarantee that any investment strategy will achieve its objectives, generate profits, or avoid losses. Eventide’s values-based approach to investing may not produce desired results and could result in underperformance compared with other investments. Any reference to Eventide’s Business 360® approach is provided for illustrative purposes only and indicates a general framework of guiding principles that inform Eventide’s overall research process. Investing involves risk including the possible loss of principal. Past performance does not guarantee future results.